Transformative is a healthcare startup developing software that predicts sudden cardiac arrest.
Transformative's mission is to collect and translate clinical data into real-time, predictive assessments that guide the actions of patients and healthcare providers.
Transformative was founded in 2016 by Josh Oppenheimer, Marek Sirendi and Marek Rei. The company is headquartered in New York and London.
Transformative's uses cutting-edge machine learning techniques employed at CERN's Large Hadron Collider to identify subtle changes preceding patient deterioration that are invisible to both physicians and standard patient monitoring software, transforming the patient monitoring paradigm from reactive to predictive.
Transformative's first patented technology—built using the largest database of its kind—identifies patients at imminent risk of sudden cardiac arrest, allowing doctors and nurses to take preventive actions.
Transformative is backed by Tera Ventures, InHealth Ventures, Entrepreneur First, AI Seed and others. The company raised $1.7M in Seed round on July 27, 2020. This brings Transformative's total funding to $2.3M to date.